BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34215155)

  • 1. Cortical neuroanatomical changes related to specific neuropsychological deficits in subcortical vascular cognitive impairment.
    Kang SH; Park YH; Kim JP; Kim JS; Kim CH; Jang H; Kim HJ; Koh SB; Na DL; Chin J; Seo SW
    Neuroimage Clin; 2021; 30():102685. PubMed ID: 34215155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct spatiotemporal patterns of cortical thinning in Alzheimer's disease-type cognitive impairment and subcortical vascular cognitive impairment.
    Kim J; Kim J; Park YH; Yoo H; Kim JP; Jang H; Park H; Seo SW
    Commun Biol; 2024 Feb; 7(1):198. PubMed ID: 38368479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.
    Jang H; Kim HJ; Park S; Park YH; Choe Y; Cho H; Lyoo CH; Yoon U; Lee JS; Kim Y; Kim SJ; Kim JP; Jung YH; Ryu YH; Choi JY; Moon SH; Seong JK; DeCarli C; Weiner MW; Lockhart SN; Cho SH; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):292-303. PubMed ID: 31471715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
    Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
    Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early- vs late-onset subcortical vascular cognitive impairment.
    Jang YK; Kwon H; Kim YJ; Jung NY; Lee JS; Lee J; Chin J; Im K; Jeon S; Lee JM; Seong JK; Kim JH; Kim S; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW; Kim HJ
    Neurology; 2016 Feb; 86(6):527-34. PubMed ID: 26764026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent effects of amyloid and vascular markers on long-term functional outcomes: An 8-year longitudinal study of subcortical vascular cognitive impairment.
    Kang SH; Woo SY; Kim S; Kim JP; Jang H; Koh SB; Na DL; Kim HJ; Seo SW
    Eur J Neurol; 2022 Feb; 29(2):413-421. PubMed ID: 34716964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.
    Chung SJ; Jeon S; Yoo HS; Lee YH; Yun M; Lee SK; Lee PH; Sohn YH; Evans AC; Ye BS
    J Alzheimers Dis; 2020; 73(3):873-885. PubMed ID: 31868668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment.
    Jung NY; Han CE; Kim HJ; Yoo SW; Kim HJ; Kim EJ; Na DL; Lockhart SN; Jagust WJ; Seong JK; Seo SW
    J Alzheimers Dis; 2016; 50(4):1125-35. PubMed ID: 26836179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer's disease: a surface-based morphometric analysis.
    Ahn HJ; Seo SW; Chin J; Suh MK; Lee BH; Kim ST; Im K; Lee JM; Lee JH; Heilman KM; Na DL
    Neuropsychologia; 2011 Dec; 49(14):3931-45. PubMed ID: 22019776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.
    Jung NY; Han JC; Ong YT; Cheung CY; Chen CP; Wong TY; Kim HJ; Kim YJ; Lee J; Lee JS; Jang YK; Kee C; Lee KH; Kim EJ; Seo SW; Na DL
    J Neurol Sci; 2019 Jan; 396():94-101. PubMed ID: 30447606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Cerebrovascular Disease in Amyloid Deposition.
    Noh Y; Seo SW; Jeon S; Lee JM; Kim JS; Lee JH; Kim JH; Kim GH; Ye BS; Cho H; Kim HJ; Yoon CW; Choe YS; Lee KH; Weiner MW; Na DL
    J Alzheimers Dis; 2016 Oct; 54(3):1015-1026. PubMed ID: 27567803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological Profile of Early Cognitive Impairment in Cerebral Small Vessel Disease.
    Seki M; Yoshizawa H; Hosoya M; Kitagawa K
    Cerebrovasc Dis; 2022; 51(5):600-607. PubMed ID: 35378532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.
    Yoo HS; Jeon S; Chung SJ; Yun M; Lee PH; Sohn YH; Evans AC; Ye BS
    Alzheimers Dement; 2018 Oct; 14(10):1243-1252. PubMed ID: 29936148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
    Chen HM; Zhang MM; Wang YL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
    Sanford R; Strain J; Dadar M; Maranzano J; Bonnet A; Mayo NE; Scott SC; Fellows LK; Ances BM; Collins DL
    AIDS; 2019 Jun; 33(7):1197-1205. PubMed ID: 30870193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neural correlates of motor intentional disorders in patients with subcortical vascular cognitive impairment.
    Kim GH; Seo SW; Jung K; Kwon OH; Kwon H; Kim JH; Roh JH; Kim MJ; Lee BH; Yoon DS; Hwang JW; Lee JM; Jeong JH; You H; Heilman KM; Na DL
    J Neurol; 2016 Jan; 263(1):89-99. PubMed ID: 26514838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Functional Connectivity and Structural Atrophy in Subcortical Vascular Cognitive Impairment: Relationship with Cognitive Impairments.
    Zhou X; Hu X; Zhang C; Wang H; Zhu X; Xu L; Sun Z; Yu Y
    Front Aging Neurosci; 2016; 8():14. PubMed ID: 26869922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cholinergic pathway disruption on cortical and subcortical volumes in subcortical vascular cognitive impairment.
    Lim JS; Kwon HM; Lee YS
    Eur J Neurol; 2020 Jan; 27(1):210-212. PubMed ID: 31444924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia.
    Swartz RH; Stuss DT; Gao F; Black SE
    Stroke; 2008 Mar; 39(3):822-30. PubMed ID: 18258840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.